Cargando...
Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis
BACKGROUND: Oral 5‐aminosalicylic (5‐ASA) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. Previously, it was found that 5‐ASA drugs were more effective than placebo but had a statistically significant therapeutic inferiority...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2016
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045447/ https://ncbi.nlm.nih.gov/pubmed/27158764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000544.pub4 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|